Anxiolytic compounds: perspectives in drug development
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Chichester
Wiley
1996
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | VIII, 163 S: Ill. |
| ISBN: | 0471957135 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV011519586 | ||
| 003 | DE-604 | ||
| 005 | 20011025 | ||
| 007 | t | ||
| 008 | 970904s1996 a||| |||| 00||| eng d | ||
| 020 | |a 0471957135 |9 0-471-95713-5 | ||
| 035 | |a (OCoLC)33078913 | ||
| 035 | |a (DE-599)BVBBV011519586 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-20 | ||
| 050 | 0 | |a RM333 | |
| 082 | 0 | |a 615/.7882 |2 20 | |
| 100 | 1 | |a Cutler, Neal R. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Anxiolytic compounds |b perspectives in drug development |c Neal R. Cutler and John J. Sramek, Neil M. Kurtz |
| 264 | 1 | |a Chichester |b Wiley |c 1996 | |
| 300 | |a VIII, 163 S: |b Ill. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 7 | |a Tranquillisants |2 ram | |
| 650 | 4 | |a Anti-Anxiety Agents | |
| 650 | 4 | |a Tranquilizing drugs |x Development | |
| 650 | 0 | 7 | |a Tranquilizer |0 (DE-588)4060615-6 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Tranquilizer |0 (DE-588)4060615-6 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Sramek, John J. |e Verfasser |4 aut | |
| 700 | 1 | |a Kurtz, Neil M. |e Verfasser |4 aut | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007751566&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-007751566 | ||
Datensatz im Suchindex
| _version_ | 1804126039484399616 |
|---|---|
| adam_text | N *- 3 H 2 - 0^0 ANXIOLYTIC COMPOUNDS PERSPECTIVES IN DRUG DEVELOPMENT
NEAL R. CUTLER AND JOHN J. SRAMEK CALIFORNIA CLINICAL TRIALS,
CALIFORNIA, USA NEIL M. KURTZ WORLDWIDE CLINICAL TRIALS, LONDON, UK JOHN
WILEY & SONS CHICHESTER * NEW * YORK * BRISBANE * TORONTO * SINGAPORE
CONTENTS PREFACE VII ABBREVIATIONS USED IN THE TEXT IX 1 PERSPECTIVES ON
THE WORLDWIDE MARKET FOR ANXIOLYTICS 1 2 A RETROSPECTIVE ANALYSIS OF THE
DRUG DEVELOPMENT OF CURRENTLY APPROVED ANXIOLYTICS 31 3 METHODOLOGICAL
ISSUES IN DRUG DEVELOPMENT 61 4 NOVEL ANXIOLYTICS 109 5 ROLE OF THE
BRIDGING STUDY IN FACILITATING DEVELOPMENT OF POTENTIAL ANXIOLYTICS
139 6 PERSPECTIVES ON INTERNATIONAL REGULATORY REQUIREMENTS 153
CONCLUDING REMARKS 157 INDEX 159
|
| any_adam_object | 1 |
| author | Cutler, Neal R. Sramek, John J. Kurtz, Neil M. |
| author_facet | Cutler, Neal R. Sramek, John J. Kurtz, Neil M. |
| author_role | aut aut aut |
| author_sort | Cutler, Neal R. |
| author_variant | n r c nr nrc j j s jj jjs n m k nm nmk |
| building | Verbundindex |
| bvnumber | BV011519586 |
| callnumber-first | R - Medicine |
| callnumber-label | RM333 |
| callnumber-raw | RM333 |
| callnumber-search | RM333 |
| callnumber-sort | RM 3333 |
| callnumber-subject | RM - Therapeutics and Pharmacology |
| ctrlnum | (OCoLC)33078913 (DE-599)BVBBV011519586 |
| dewey-full | 615/.7882 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.7882 |
| dewey-search | 615/.7882 |
| dewey-sort | 3615 47882 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01394nam a2200385 c 4500</leader><controlfield tag="001">BV011519586</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20011025 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">970904s1996 a||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0471957135</subfield><subfield code="9">0-471-95713-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)33078913</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV011519586</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-20</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM333</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.7882</subfield><subfield code="2">20</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Cutler, Neal R.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Anxiolytic compounds</subfield><subfield code="b">perspectives in drug development</subfield><subfield code="c">Neal R. Cutler and John J. Sramek, Neil M. Kurtz</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Chichester</subfield><subfield code="b">Wiley</subfield><subfield code="c">1996</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">VIII, 163 S:</subfield><subfield code="b">Ill.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Tranquillisants</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anti-Anxiety Agents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tranquilizing drugs</subfield><subfield code="x">Development</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Tranquilizer</subfield><subfield code="0">(DE-588)4060615-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Tranquilizer</subfield><subfield code="0">(DE-588)4060615-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sramek, John J.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kurtz, Neil M.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007751566&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007751566</subfield></datafield></record></collection> |
| id | DE-604.BV011519586 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T18:11:07Z |
| institution | BVB |
| isbn | 0471957135 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-007751566 |
| oclc_num | 33078913 |
| open_access_boolean | |
| owner | DE-20 |
| owner_facet | DE-20 |
| physical | VIII, 163 S: Ill. |
| publishDate | 1996 |
| publishDateSearch | 1996 |
| publishDateSort | 1996 |
| publisher | Wiley |
| record_format | marc |
| spelling | Cutler, Neal R. Verfasser aut Anxiolytic compounds perspectives in drug development Neal R. Cutler and John J. Sramek, Neil M. Kurtz Chichester Wiley 1996 VIII, 163 S: Ill. txt rdacontent n rdamedia nc rdacarrier Tranquillisants ram Anti-Anxiety Agents Tranquilizing drugs Development Tranquilizer (DE-588)4060615-6 gnd rswk-swf Tranquilizer (DE-588)4060615-6 s DE-604 Sramek, John J. Verfasser aut Kurtz, Neil M. Verfasser aut GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007751566&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Cutler, Neal R. Sramek, John J. Kurtz, Neil M. Anxiolytic compounds perspectives in drug development Tranquillisants ram Anti-Anxiety Agents Tranquilizing drugs Development Tranquilizer (DE-588)4060615-6 gnd |
| subject_GND | (DE-588)4060615-6 |
| title | Anxiolytic compounds perspectives in drug development |
| title_auth | Anxiolytic compounds perspectives in drug development |
| title_exact_search | Anxiolytic compounds perspectives in drug development |
| title_full | Anxiolytic compounds perspectives in drug development Neal R. Cutler and John J. Sramek, Neil M. Kurtz |
| title_fullStr | Anxiolytic compounds perspectives in drug development Neal R. Cutler and John J. Sramek, Neil M. Kurtz |
| title_full_unstemmed | Anxiolytic compounds perspectives in drug development Neal R. Cutler and John J. Sramek, Neil M. Kurtz |
| title_short | Anxiolytic compounds |
| title_sort | anxiolytic compounds perspectives in drug development |
| title_sub | perspectives in drug development |
| topic | Tranquillisants ram Anti-Anxiety Agents Tranquilizing drugs Development Tranquilizer (DE-588)4060615-6 gnd |
| topic_facet | Tranquillisants Anti-Anxiety Agents Tranquilizing drugs Development Tranquilizer |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007751566&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT cutlernealr anxiolyticcompoundsperspectivesindrugdevelopment AT sramekjohnj anxiolyticcompoundsperspectivesindrugdevelopment AT kurtzneilm anxiolyticcompoundsperspectivesindrugdevelopment |